Travis brings back Jared Bergquist, a Las Vegas-based dental broker with two decades of transitions under his belt, for a blunt breakdown of why a DSO sale isn’t always the win it’s made out to be.

What’s covered:

• Reason one, transparency. How EBITDA calculations, complicated contracts, and vague post sale expectations leave sellers confused about what they actually agreed to
• Reason two, financial risk. Why earnouts and equity rollovers depend on a private equity market that has cooled significantly in the last few years, and why some sellers are still waiting on money they were promised
• A real example of a client who would have made less money selling to a DSO than by simply staying put
• Reason three, legacy. A gut wrenching story about a Summerlin practice owner who watched her staff and patients walk away within a year and a half of selling
• Why corporations are financially pressured to increase production fast, whether the team and patients like it or not
• The bonus round, Jared’s own answer to the DSO problem: skipping the middleman by co founding Las Vegas Dental Management, a dentist owned collective aiming for private equity multiples without giving up control to a traditional DSO

A candid, insider’s view on the tradeoffs of corporate dentistry from someone who has helped broker it hundreds of times. Tune in.

LET’S CONNECT

Instagram: https://www.instagram.com/travisslade.cpa/

TikTok: https://www.tiktok.com/@travis.slade.cpa